China National Medicines Corp Ltd (600511) — Cash Flow Reinvestment Rate
China National Medicines Corp Ltd (600511) has a Cash Flow Reinvestment Rate of 0.11x as of June 2025, reinvesting CN¥42.55 Million (capex CN¥13.23 Million plus investments CN¥29.33 Million) from operating cash flow of CN¥382.74 Million. Explore China National Medicines Corp Ltd (600511) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China National Medicines Corp Ltd Cash Flow Reinvestment Rate (2002–2024)
Historical reinvestment intensity for China National Medicines Corp Ltd across 22 annual periods. Also explore China National Medicines Corp Ltd total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for China National Medicines Corp Ltd (2002–2024)
Year-by-year capital reinvestment analysis for China National Medicines Corp Ltd. For live market cap and broader valuation context, see market value of China National Medicines Corp Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.11x | CN¥177.45 Million | CN¥1.66 Billion | CN¥130.77 Million | ▲ +6.3% |
| 2023 | 0.10x | CN¥274.44 Million | CN¥2.73 Billion | CN¥145.12 Million | ▼ -14.5% |
| 2022 | 0.12x | CN¥282.10 Million | CN¥2.40 Billion | CN¥129.78 Million | ▲ +108.0% |
| 2021 | 0.06x | CN¥110.82 Million | CN¥1.96 Billion | CN¥95.07 Million | ▲ +2.5% |
| 2020 | 0.06x | CN¥71.92 Million | CN¥1.30 Billion | CN¥69.05 Million | ▲ +13.3% |
| 2019 | 0.05x | CN¥86.62 Million | CN¥1.78 Billion | CN¥85.72 Million | ▼ -75.2% |
| 2018 | 0.20x | CN¥192.66 Million | CN¥981.65 Million | CN¥132.46 Million | ▲ +79.3% |
| 2017 | 0.11x | CN¥117.63 Million | CN¥1.07 Billion | CN¥73.25 Million | ▼ -20.3% |
| 2016 | 0.14x | CN¥81.25 Million | CN¥591.25 Million | CN¥39.88 Million | ▼ -11.8% |
| 2015 | 0.16x | CN¥68.62 Million | CN¥440.29 Million | CN¥68.47 Million | ▼ -77.0% |
| 2014 | 0.68x | CN¥148.22 Million | CN¥218.94 Million | CN¥148.22 Million | ▲ +3.3% |
| 2013 | 0.66x | CN¥121.66 Million | CN¥185.56 Million | CN¥121.66 Million | ▼ -28.2% |
| 2012 | 0.91x | CN¥169.65 Million | CN¥185.87 Million | CN¥169.65 Million | ▲ +1105.7% |
| 2010 | 0.08x | CN¥24.09 Million | CN¥318.21 Million | CN¥24.09 Million | ▼ -13.5% |
| 2009 | 0.09x | CN¥22.33 Million | CN¥255.18 Million | CN¥22.33 Million | ▲ +17.2% |
| 2008 | 0.07x | CN¥16.21 Million | CN¥217.10 Million | CN¥16.21 Million | ▼ -31.1% |
| 2007 | 0.11x | CN¥8.61 Million | CN¥79.48 Million | CN¥8.61 Million | ▼ -44.7% |
| 2006 | 0.20x | CN¥23.81 Million | CN¥121.50 Million | CN¥23.81 Million | ▼ -56.2% |
| 2005 | 0.45x | CN¥41.24 Million | CN¥92.20 Million | CN¥41.24 Million | ▼ -74.7% |
| 2004 | 1.77x | CN¥87.08 Million | CN¥49.18 Million | CN¥87.08 Million | ▼ -99.0% |
| 2003 | 172.79x | CN¥90.92 Million | CN¥526.15K | CN¥90.92 Million | ▲ +18401.7% |
| 2002 | 0.93x | CN¥14.19 Million | CN¥15.19 Million | CN¥14.19 Million | — |